nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—Captopril—systemic scleroderma	0.241	0.366	CbGbCtD
Gatifloxacin—ALB—Mycophenolate mofetil—systemic scleroderma	0.19	0.288	CbGbCtD
Gatifloxacin—ALB—Prednisone—systemic scleroderma	0.152	0.23	CbGbCtD
Gatifloxacin—ALB—Methotrexate—systemic scleroderma	0.076	0.116	CbGbCtD
Gatifloxacin—Dyspnoea—Leflunomide—systemic scleroderma	0.000299	0.000874	CcSEcCtD
Gatifloxacin—Hypotension—Mycophenolic acid—systemic scleroderma	0.000299	0.000874	CcSEcCtD
Gatifloxacin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000298	0.00087	CcSEcCtD
Gatifloxacin—Dyspepsia—Leflunomide—systemic scleroderma	0.000295	0.000863	CcSEcCtD
Gatifloxacin—Pancreatitis—Prednisone—systemic scleroderma	0.000295	0.000863	CcSEcCtD
Gatifloxacin—Vomiting—Mometasone—systemic scleroderma	0.000295	0.000861	CcSEcCtD
Gatifloxacin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000293	0.000856	CcSEcCtD
Gatifloxacin—Rash—Mometasone—systemic scleroderma	0.000292	0.000854	CcSEcCtD
Gatifloxacin—Asthenia—Captopril—systemic scleroderma	0.000292	0.000854	CcSEcCtD
Gatifloxacin—Dermatitis—Mometasone—systemic scleroderma	0.000292	0.000854	CcSEcCtD
Gatifloxacin—Decreased appetite—Leflunomide—systemic scleroderma	0.000292	0.000853	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000292	0.000852	CcSEcCtD
Gatifloxacin—Confusional state—Lisinopril—systemic scleroderma	0.000291	0.00085	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000291	0.000849	CcSEcCtD
Gatifloxacin—Headache—Mometasone—systemic scleroderma	0.00029	0.000849	CcSEcCtD
Gatifloxacin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00029	0.000848	CcSEcCtD
Gatifloxacin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000289	0.000846	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000288	0.000843	CcSEcCtD
Gatifloxacin—Oedema—Lisinopril—systemic scleroderma	0.000288	0.000843	CcSEcCtD
Gatifloxacin—Pruritus—Captopril—systemic scleroderma	0.000288	0.000842	CcSEcCtD
Gatifloxacin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000287	0.00084	CcSEcCtD
Gatifloxacin—Constipation—Leflunomide—systemic scleroderma	0.000287	0.000839	CcSEcCtD
Gatifloxacin—Infection—Lisinopril—systemic scleroderma	0.000286	0.000837	CcSEcCtD
Gatifloxacin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000285	0.000834	CcSEcCtD
Gatifloxacin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000285	0.000832	CcSEcCtD
Gatifloxacin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000831	CcSEcCtD
Gatifloxacin—Shock—Lisinopril—systemic scleroderma	0.000284	0.000829	CcSEcCtD
Gatifloxacin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000283	0.000827	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000282	0.000825	CcSEcCtD
Gatifloxacin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000282	0.000824	CcSEcCtD
Gatifloxacin—Neutropenia—Prednisone—systemic scleroderma	0.000282	0.000823	CcSEcCtD
Gatifloxacin—Tachycardia—Lisinopril—systemic scleroderma	0.000281	0.000823	CcSEcCtD
Gatifloxacin—Body temperature increased—Azathioprine—systemic scleroderma	0.000281	0.000821	CcSEcCtD
Gatifloxacin—Abdominal pain—Azathioprine—systemic scleroderma	0.000281	0.000821	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000279	0.000815	CcSEcCtD
Gatifloxacin—Diarrhoea—Captopril—systemic scleroderma	0.000279	0.000814	CcSEcCtD
Gatifloxacin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000278	0.000813	CcSEcCtD
Gatifloxacin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000813	CcSEcCtD
Gatifloxacin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000811	CcSEcCtD
Gatifloxacin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000276	0.000808	CcSEcCtD
Gatifloxacin—Nausea—Mometasone—systemic scleroderma	0.000275	0.000805	CcSEcCtD
Gatifloxacin—Anorexia—Lisinopril—systemic scleroderma	0.000275	0.000803	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000274	0.000802	CcSEcCtD
Gatifloxacin—Ataxia—Methotrexate—systemic scleroderma	0.000274	0.0008	CcSEcCtD
Gatifloxacin—Constipation—Mycophenolic acid—systemic scleroderma	0.000274	0.0008	CcSEcCtD
Gatifloxacin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000274	0.0008	CcSEcCtD
Gatifloxacin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000795	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Prednisone—systemic scleroderma	0.000272	0.000794	CcSEcCtD
Gatifloxacin—Hypotension—Lisinopril—systemic scleroderma	0.000269	0.000788	CcSEcCtD
Gatifloxacin—Dizziness—Captopril—systemic scleroderma	0.000269	0.000787	CcSEcCtD
Gatifloxacin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000784	CcSEcCtD
Gatifloxacin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000781	CcSEcCtD
Gatifloxacin—Urticaria—Leflunomide—systemic scleroderma	0.000267	0.000779	CcSEcCtD
Gatifloxacin—Body temperature increased—Leflunomide—systemic scleroderma	0.000265	0.000775	CcSEcCtD
Gatifloxacin—Abdominal pain—Leflunomide—systemic scleroderma	0.000265	0.000775	CcSEcCtD
Gatifloxacin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000264	0.000771	CcSEcCtD
Gatifloxacin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00077	CcSEcCtD
Gatifloxacin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00077	CcSEcCtD
Gatifloxacin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00077	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000263	0.000768	CcSEcCtD
Gatifloxacin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000768	CcSEcCtD
Gatifloxacin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000262	0.000765	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000262	0.000765	CcSEcCtD
Gatifloxacin—Insomnia—Lisinopril—systemic scleroderma	0.000261	0.000762	CcSEcCtD
Gatifloxacin—Paraesthesia—Lisinopril—systemic scleroderma	0.000259	0.000757	CcSEcCtD
Gatifloxacin—Vomiting—Captopril—systemic scleroderma	0.000259	0.000757	CcSEcCtD
Gatifloxacin—Dyspnoea—Lisinopril—systemic scleroderma	0.000257	0.000751	CcSEcCtD
Gatifloxacin—Rash—Captopril—systemic scleroderma	0.000257	0.00075	CcSEcCtD
Gatifloxacin—Dermatitis—Captopril—systemic scleroderma	0.000256	0.00075	CcSEcCtD
Gatifloxacin—Somnolence—Lisinopril—systemic scleroderma	0.000256	0.000749	CcSEcCtD
Gatifloxacin—Headache—Captopril—systemic scleroderma	0.000255	0.000746	CcSEcCtD
Gatifloxacin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000745	CcSEcCtD
Gatifloxacin—Dyspepsia—Lisinopril—systemic scleroderma	0.000254	0.000742	CcSEcCtD
Gatifloxacin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000253	0.00074	CcSEcCtD
Gatifloxacin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000253	0.00074	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000738	CcSEcCtD
Gatifloxacin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000738	CcSEcCtD
Gatifloxacin—Asthma—Methotrexate—systemic scleroderma	0.000252	0.000736	CcSEcCtD
Gatifloxacin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000734	CcSEcCtD
Gatifloxacin—Decreased appetite—Lisinopril—systemic scleroderma	0.000251	0.000733	CcSEcCtD
Gatifloxacin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000726	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000723	CcSEcCtD
Gatifloxacin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000247	0.000723	CcSEcCtD
Gatifloxacin—Pancreatitis—Methotrexate—systemic scleroderma	0.000247	0.000721	CcSEcCtD
Gatifloxacin—Constipation—Lisinopril—systemic scleroderma	0.000247	0.000721	CcSEcCtD
Gatifloxacin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000721	CcSEcCtD
Gatifloxacin—Bradycardia—Prednisone—systemic scleroderma	0.000245	0.000717	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000714	CcSEcCtD
Gatifloxacin—Diarrhoea—Azathioprine—systemic scleroderma	0.000243	0.000711	CcSEcCtD
Gatifloxacin—Nausea—Captopril—systemic scleroderma	0.000242	0.000707	CcSEcCtD
Gatifloxacin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000704	CcSEcCtD
Gatifloxacin—Asthenia—Leflunomide—systemic scleroderma	0.000241	0.000704	CcSEcCtD
Gatifloxacin—Hallucination—Prednisone—systemic scleroderma	0.00024	0.000701	CcSEcCtD
Gatifloxacin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000238	0.000694	CcSEcCtD
Gatifloxacin—Pruritus—Leflunomide—systemic scleroderma	0.000237	0.000694	CcSEcCtD
Gatifloxacin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000236	0.00069	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000236	0.000689	CcSEcCtD
Gatifloxacin—Dysuria—Methotrexate—systemic scleroderma	0.000235	0.000688	CcSEcCtD
Gatifloxacin—Neutropenia—Methotrexate—systemic scleroderma	0.000235	0.000688	CcSEcCtD
Gatifloxacin—Dizziness—Azathioprine—systemic scleroderma	0.000235	0.000687	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000673	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00023	0.000671	CcSEcCtD
Gatifloxacin—Asthenia—Mycophenolic acid—systemic scleroderma	0.00023	0.000671	CcSEcCtD
Gatifloxacin—Diarrhoea—Leflunomide—systemic scleroderma	0.00023	0.000671	CcSEcCtD
Gatifloxacin—Urticaria—Lisinopril—systemic scleroderma	0.000229	0.00067	CcSEcCtD
Gatifloxacin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000668	CcSEcCtD
Gatifloxacin—Abdominal pain—Lisinopril—systemic scleroderma	0.000228	0.000666	CcSEcCtD
Gatifloxacin—Body temperature increased—Lisinopril—systemic scleroderma	0.000228	0.000666	CcSEcCtD
Gatifloxacin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000663	CcSEcCtD
Gatifloxacin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000226	0.000662	CcSEcCtD
Gatifloxacin—Vomiting—Azathioprine—systemic scleroderma	0.000226	0.00066	CcSEcCtD
Gatifloxacin—Eye disorder—Prednisone—systemic scleroderma	0.000225	0.000658	CcSEcCtD
Gatifloxacin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000658	CcSEcCtD
Gatifloxacin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000656	CcSEcCtD
Gatifloxacin—Rash—Azathioprine—systemic scleroderma	0.000224	0.000655	CcSEcCtD
Gatifloxacin—Dermatitis—Azathioprine—systemic scleroderma	0.000224	0.000654	CcSEcCtD
Gatifloxacin—Headache—Azathioprine—systemic scleroderma	0.000223	0.000651	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000222	0.00065	CcSEcCtD
Gatifloxacin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00065	CcSEcCtD
Gatifloxacin—Dizziness—Leflunomide—systemic scleroderma	0.000222	0.000649	CcSEcCtD
Gatifloxacin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000642	CcSEcCtD
Gatifloxacin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000219	0.00064	CcSEcCtD
Gatifloxacin—Stomatitis—Methotrexate—systemic scleroderma	0.000219	0.000639	CcSEcCtD
Gatifloxacin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000218	0.000638	CcSEcCtD
Gatifloxacin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000631	CcSEcCtD
Gatifloxacin—Sweating—Methotrexate—systemic scleroderma	0.000215	0.000629	CcSEcCtD
Gatifloxacin—Haematuria—Methotrexate—systemic scleroderma	0.000214	0.000625	CcSEcCtD
Gatifloxacin—Vomiting—Leflunomide—systemic scleroderma	0.000213	0.000624	CcSEcCtD
Gatifloxacin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000212	0.000621	CcSEcCtD
Gatifloxacin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000212	0.000619	CcSEcCtD
Gatifloxacin—Epistaxis—Methotrexate—systemic scleroderma	0.000212	0.000619	CcSEcCtD
Gatifloxacin—Rash—Leflunomide—systemic scleroderma	0.000212	0.000618	CcSEcCtD
Gatifloxacin—Dermatitis—Leflunomide—systemic scleroderma	0.000211	0.000618	CcSEcCtD
Gatifloxacin—Nausea—Azathioprine—systemic scleroderma	0.000211	0.000617	CcSEcCtD
Gatifloxacin—Headache—Leflunomide—systemic scleroderma	0.00021	0.000614	CcSEcCtD
Gatifloxacin—Erythema—Prednisone—systemic scleroderma	0.00021	0.000613	CcSEcCtD
Gatifloxacin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000608	CcSEcCtD
Gatifloxacin—Asthenia—Lisinopril—systemic scleroderma	0.000207	0.000605	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000604	CcSEcCtD
Gatifloxacin—Pruritus—Lisinopril—systemic scleroderma	0.000204	0.000596	CcSEcCtD
Gatifloxacin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000204	0.000595	CcSEcCtD
Gatifloxacin—Rash—Mycophenolic acid—systemic scleroderma	0.000202	0.00059	CcSEcCtD
Gatifloxacin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000202	0.000589	CcSEcCtD
Gatifloxacin—Hepatitis—Methotrexate—systemic scleroderma	0.000201	0.000589	CcSEcCtD
Gatifloxacin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000587	CcSEcCtD
Gatifloxacin—Headache—Mycophenolic acid—systemic scleroderma	0.000201	0.000586	CcSEcCtD
Gatifloxacin—Pharyngitis—Methotrexate—systemic scleroderma	0.0002	0.000584	CcSEcCtD
Gatifloxacin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000584	CcSEcCtD
Gatifloxacin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000584	CcSEcCtD
Gatifloxacin—Nausea—Leflunomide—systemic scleroderma	0.000199	0.000583	CcSEcCtD
Gatifloxacin—Vision blurred—Prednisone—systemic scleroderma	0.000198	0.000578	CcSEcCtD
Gatifloxacin—Diarrhoea—Lisinopril—systemic scleroderma	0.000197	0.000577	CcSEcCtD
Gatifloxacin—Visual impairment—Methotrexate—systemic scleroderma	0.000194	0.000567	CcSEcCtD
Gatifloxacin—Agitation—Prednisone—systemic scleroderma	0.000193	0.000564	CcSEcCtD
Gatifloxacin—Angioedema—Prednisone—systemic scleroderma	0.000192	0.00056	CcSEcCtD
Gatifloxacin—Dizziness—Lisinopril—systemic scleroderma	0.000191	0.000557	CcSEcCtD
Gatifloxacin—Erythema multiforme—Methotrexate—systemic scleroderma	0.00019	0.000557	CcSEcCtD
Gatifloxacin—Nausea—Mycophenolic acid—systemic scleroderma	0.00019	0.000556	CcSEcCtD
Gatifloxacin—Vertigo—Prednisone—systemic scleroderma	0.000188	0.000551	CcSEcCtD
Gatifloxacin—Eye disorder—Methotrexate—systemic scleroderma	0.000188	0.00055	CcSEcCtD
Gatifloxacin—Syncope—Prednisone—systemic scleroderma	0.000188	0.00055	CcSEcCtD
Gatifloxacin—Tinnitus—Methotrexate—systemic scleroderma	0.000188	0.000549	CcSEcCtD
Gatifloxacin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000544	CcSEcCtD
Gatifloxacin—Loss of consciousness—Prednisone—systemic scleroderma	0.000184	0.000539	CcSEcCtD
Gatifloxacin—Vomiting—Lisinopril—systemic scleroderma	0.000183	0.000536	CcSEcCtD
Gatifloxacin—Rash—Lisinopril—systemic scleroderma	0.000182	0.000531	CcSEcCtD
Gatifloxacin—Convulsion—Prednisone—systemic scleroderma	0.000182	0.000531	CcSEcCtD
Gatifloxacin—Dermatitis—Lisinopril—systemic scleroderma	0.000182	0.000531	CcSEcCtD
Gatifloxacin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00053	CcSEcCtD
Gatifloxacin—Hypertension—Prednisone—systemic scleroderma	0.000181	0.000529	CcSEcCtD
Gatifloxacin—Chills—Methotrexate—systemic scleroderma	0.000181	0.000528	CcSEcCtD
Gatifloxacin—Headache—Lisinopril—systemic scleroderma	0.000181	0.000528	CcSEcCtD
Gatifloxacin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000522	CcSEcCtD
Gatifloxacin—Arthralgia—Prednisone—systemic scleroderma	0.000179	0.000522	CcSEcCtD
Gatifloxacin—Myalgia—Prednisone—systemic scleroderma	0.000179	0.000522	CcSEcCtD
Gatifloxacin—Anxiety—Prednisone—systemic scleroderma	0.000178	0.00052	CcSEcCtD
Gatifloxacin—Erythema—Methotrexate—systemic scleroderma	0.000175	0.000513	CcSEcCtD
Gatifloxacin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000505	CcSEcCtD
Gatifloxacin—Dysgeusia—Methotrexate—systemic scleroderma	0.000172	0.000502	CcSEcCtD
Gatifloxacin—Nausea—Lisinopril—systemic scleroderma	0.000171	0.000501	CcSEcCtD
Gatifloxacin—Oedema—Prednisone—systemic scleroderma	0.000171	0.000501	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000171	0.000501	CcSEcCtD
Gatifloxacin—Infection—Prednisone—systemic scleroderma	0.00017	0.000497	CcSEcCtD
Gatifloxacin—Back pain—Methotrexate—systemic scleroderma	0.00017	0.000496	CcSEcCtD
Gatifloxacin—Shock—Prednisone—systemic scleroderma	0.000168	0.000492	CcSEcCtD
Gatifloxacin—Tachycardia—Prednisone—systemic scleroderma	0.000167	0.000489	CcSEcCtD
Gatifloxacin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000488	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000166	0.000484	CcSEcCtD
Gatifloxacin—Vision blurred—Methotrexate—systemic scleroderma	0.000165	0.000483	CcSEcCtD
Gatifloxacin—Anorexia—Prednisone—systemic scleroderma	0.000163	0.000477	CcSEcCtD
Gatifloxacin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000469	CcSEcCtD
Gatifloxacin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000466	CcSEcCtD
Gatifloxacin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000465	CcSEcCtD
Gatifloxacin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000463	CcSEcCtD
Gatifloxacin—Vertigo—Methotrexate—systemic scleroderma	0.000158	0.00046	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000156	0.000456	CcSEcCtD
Gatifloxacin—Insomnia—Prednisone—systemic scleroderma	0.000155	0.000453	CcSEcCtD
Gatifloxacin—Paraesthesia—Prednisone—systemic scleroderma	0.000154	0.000449	CcSEcCtD
Gatifloxacin—Convulsion—Methotrexate—systemic scleroderma	0.000152	0.000444	CcSEcCtD
Gatifloxacin—Dyspepsia—Prednisone—systemic scleroderma	0.000151	0.000441	CcSEcCtD
Gatifloxacin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000439	CcSEcCtD
Gatifloxacin—Chest pain—Methotrexate—systemic scleroderma	0.000149	0.000436	CcSEcCtD
Gatifloxacin—Arthralgia—Methotrexate—systemic scleroderma	0.000149	0.000436	CcSEcCtD
Gatifloxacin—Myalgia—Methotrexate—systemic scleroderma	0.000149	0.000436	CcSEcCtD
Gatifloxacin—Decreased appetite—Prednisone—systemic scleroderma	0.000149	0.000435	CcSEcCtD
Gatifloxacin—Constipation—Prednisone—systemic scleroderma	0.000146	0.000428	CcSEcCtD
Gatifloxacin—Confusional state—Methotrexate—systemic scleroderma	0.000144	0.000422	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000143	0.000418	CcSEcCtD
Gatifloxacin—Infection—Methotrexate—systemic scleroderma	0.000142	0.000416	CcSEcCtD
Gatifloxacin—Feeling abnormal—Prednisone—systemic scleroderma	0.000141	0.000412	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00014	0.00041	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00014	0.000409	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000138	0.000404	CcSEcCtD
Gatifloxacin—Anorexia—Methotrexate—systemic scleroderma	0.000136	0.000399	CcSEcCtD
Gatifloxacin—Urticaria—Prednisone—systemic scleroderma	0.000136	0.000398	CcSEcCtD
Gatifloxacin—Body temperature increased—Prednisone—systemic scleroderma	0.000135	0.000396	CcSEcCtD
Gatifloxacin—Abdominal pain—Prednisone—systemic scleroderma	0.000135	0.000396	CcSEcCtD
Gatifloxacin—Hypotension—Methotrexate—systemic scleroderma	0.000134	0.000391	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00013	0.000381	CcSEcCtD
Gatifloxacin—Insomnia—Methotrexate—systemic scleroderma	0.000129	0.000378	CcSEcCtD
Gatifloxacin—Paraesthesia—Methotrexate—systemic scleroderma	0.000128	0.000376	CcSEcCtD
Gatifloxacin—Dyspnoea—Methotrexate—systemic scleroderma	0.000128	0.000373	CcSEcCtD
Gatifloxacin—Somnolence—Methotrexate—systemic scleroderma	0.000127	0.000372	CcSEcCtD
Gatifloxacin—Hypersensitivity—Prednisone—systemic scleroderma	0.000126	0.000369	CcSEcCtD
Gatifloxacin—Dyspepsia—Methotrexate—systemic scleroderma	0.000126	0.000368	CcSEcCtD
Gatifloxacin—Decreased appetite—Methotrexate—systemic scleroderma	0.000124	0.000364	CcSEcCtD
Gatifloxacin—Asthenia—Prednisone—systemic scleroderma	0.000123	0.000359	CcSEcCtD
Gatifloxacin—Pruritus—Prednisone—systemic scleroderma	0.000121	0.000354	CcSEcCtD
Gatifloxacin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000118	0.000345	CcSEcCtD
Gatifloxacin—Diarrhoea—Prednisone—systemic scleroderma	0.000117	0.000342	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000117	0.000342	CcSEcCtD
Gatifloxacin—Urticaria—Methotrexate—systemic scleroderma	0.000114	0.000332	CcSEcCtD
Gatifloxacin—Dizziness—Prednisone—systemic scleroderma	0.000113	0.000331	CcSEcCtD
Gatifloxacin—Abdominal pain—Methotrexate—systemic scleroderma	0.000113	0.000331	CcSEcCtD
Gatifloxacin—Body temperature increased—Methotrexate—systemic scleroderma	0.000113	0.000331	CcSEcCtD
Gatifloxacin—Vomiting—Prednisone—systemic scleroderma	0.000109	0.000318	CcSEcCtD
Gatifloxacin—Rash—Prednisone—systemic scleroderma	0.000108	0.000316	CcSEcCtD
Gatifloxacin—Dermatitis—Prednisone—systemic scleroderma	0.000108	0.000315	CcSEcCtD
Gatifloxacin—Headache—Prednisone—systemic scleroderma	0.000107	0.000314	CcSEcCtD
Gatifloxacin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000105	0.000308	CcSEcCtD
Gatifloxacin—Asthenia—Methotrexate—systemic scleroderma	0.000103	0.0003	CcSEcCtD
Gatifloxacin—Nausea—Prednisone—systemic scleroderma	0.000102	0.000297	CcSEcCtD
Gatifloxacin—Pruritus—Methotrexate—systemic scleroderma	0.000101	0.000296	CcSEcCtD
Gatifloxacin—Diarrhoea—Methotrexate—systemic scleroderma	9.79e-05	0.000286	CcSEcCtD
Gatifloxacin—Dizziness—Methotrexate—systemic scleroderma	9.46e-05	0.000277	CcSEcCtD
Gatifloxacin—Vomiting—Methotrexate—systemic scleroderma	9.1e-05	0.000266	CcSEcCtD
Gatifloxacin—Rash—Methotrexate—systemic scleroderma	9.02e-05	0.000264	CcSEcCtD
Gatifloxacin—Dermatitis—Methotrexate—systemic scleroderma	9.01e-05	0.000264	CcSEcCtD
Gatifloxacin—Headache—Methotrexate—systemic scleroderma	8.96e-05	0.000262	CcSEcCtD
Gatifloxacin—Nausea—Methotrexate—systemic scleroderma	8.5e-05	0.000248	CcSEcCtD
